|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
|
US5928905A
(en)
|
1995-04-18 |
1999-07-27 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
US5834252A
(en)
|
1995-04-18 |
1998-11-10 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
|
US6117679A
(en)
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6165793A
(en)
|
1996-03-25 |
2000-12-26 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6395547B1
(en)
|
1994-02-17 |
2002-05-28 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6309883B1
(en)
|
1994-02-17 |
2001-10-30 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
US6995017B1
(en)
|
1994-02-17 |
2006-02-07 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US20060257890A1
(en)
|
1996-05-20 |
2006-11-16 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
FI964808A0
(fi)
|
1994-06-03 |
1996-12-02 |
Novo Nordisk Biotech Inc |
Puhdistetut Myceliophthora lakkaasit ja niitä koodaavat nukleiinihapot
|
|
CN101659926A
(zh)
|
1994-06-30 |
2010-03-03 |
诺沃奇梅兹有限公司 |
非毒性、非产毒性、非致病性镰孢属表达系统及所用启动子和终止子
|
|
FI104465B
(fi)
|
1995-06-14 |
2000-02-15 |
Valio Oy |
Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
|
|
US6506602B1
(en)
|
1996-03-25 |
2003-01-14 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6096548A
(en)
|
1996-03-25 |
2000-08-01 |
Maxygen, Inc. |
Method for directing evolution of a virus
|
|
KR100570935B1
(ko)
|
1997-01-17 |
2006-04-13 |
맥시겐, 인크. |
반복적 서열 재조합에 의한 전세포 및 유기체의 개량 방법
|
|
WO1998031816A1
(en)
|
1997-01-17 |
1998-07-23 |
Regents Of The University Of Minnesota |
Dna molecules and protein displaying improved triazine compound degrading ability
|
|
US7148054B2
(en)
|
1997-01-17 |
2006-12-12 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
|
US6326204B1
(en)
|
1997-01-17 |
2001-12-04 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
|
US6537746B2
(en)
|
1997-12-08 |
2003-03-25 |
Maxygen, Inc. |
Method for creating polynucleotide and polypeptide sequences
|
|
US6484105B2
(en)
|
1998-04-02 |
2002-11-19 |
Maxyag, Inc. |
Method for obtaining a plant with a genetic lesion in a gene sequence
|
|
IL139093A0
(en)
|
1998-05-01 |
2001-11-25 |
Maxygen Inc |
Optimization of pest resistance genes using dna shuffling
|
|
IL140125A0
(en)
|
1998-06-17 |
2002-02-10 |
Maxygen Inc |
Method for producing polynucleotides with desired properties
|
|
US6365408B1
(en)
|
1998-06-19 |
2002-04-02 |
Maxygen, Inc. |
Methods of evolving a polynucleotides by mutagenesis and recombination
|
|
JP2002522072A
(ja)
|
1998-08-12 |
2002-07-23 |
マキシジェン， インコーポレイテッド |
工業用化学薬品の製造のためのモノオキシゲナーゼ遺伝子のｄｎａシャッフリング。
|
|
JP2002526107A
(ja)
|
1998-10-07 |
2002-08-20 |
マキシジェン， インコーポレイテッド |
マイコトキシンの解毒のための核酸を生成するためのｄｎａシャッフリング
|
|
WO2000028018A1
(en)
|
1998-11-10 |
2000-05-18 |
Maxygen, Inc. |
Modified adp-glucose pyrophosphorylase for improvement and optimization of plant phenotypes
|
|
JP4221100B2
(ja)
|
1999-01-13 |
2009-02-12 |
エルピーダメモリ株式会社 |
半導体装置
|
|
US6917882B2
(en)
|
1999-01-19 |
2005-07-12 |
Maxygen, Inc. |
Methods for making character strings, polynucleotides and polypeptides having desired characteristics
|
|
US6436675B1
(en)
|
1999-09-28 |
2002-08-20 |
Maxygen, Inc. |
Use of codon-varied oligonucleotide synthesis for synthetic shuffling
|
|
US6376246B1
(en)
|
1999-02-05 |
2002-04-23 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
|
US6368861B1
(en)
|
1999-01-19 |
2002-04-09 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
|
US7873477B1
(en)
|
2001-08-21 |
2011-01-18 |
Codexis Mayflower Holdings, Llc |
Method and system using systematically varied data libraries
|
|
US8457903B1
(en)
|
1999-01-19 |
2013-06-04 |
Codexis Mayflower Holdings, Llc |
Method and/or apparatus for determining codons
|
|
US6961664B2
(en)
|
1999-01-19 |
2005-11-01 |
Maxygen |
Methods of populating data structures for use in evolutionary simulations
|
|
US20070065838A1
(en)
|
1999-01-19 |
2007-03-22 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
|
US7024312B1
(en)
|
1999-01-19 |
2006-04-04 |
Maxygen, Inc. |
Methods for making character strings, polynucleotides and polypeptides having desired characteristics
|
|
US7702464B1
(en)
|
2001-08-21 |
2010-04-20 |
Maxygen, Inc. |
Method and apparatus for codon determining
|
|
ES2341217T3
(es)
|
1999-01-19 |
2010-06-17 |
Maxygen, Inc. |
Recombinacion de acidos nucleicos mediada por oligonucleotidos.
|
|
JP2003524394A
(ja)
|
1999-02-11 |
2003-08-19 |
マキシジェン， インコーポレイテッド |
ハイスループット質量分析法
|
|
AU3391900A
(en)
|
1999-03-05 |
2000-09-21 |
Maxygen, Inc. |
Encryption of traits using split gene sequences
|
|
US6703240B1
(en)
|
1999-04-13 |
2004-03-09 |
Maxygar, Inc. |
Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
|
|
US7430477B2
(en)
|
1999-10-12 |
2008-09-30 |
Maxygen, Inc. |
Methods of populating data structures for use in evolutionary simulations
|
|
US6519065B1
(en)
|
1999-11-05 |
2003-02-11 |
Jds Fitel Inc. |
Chromatic dispersion compensation device
|
|
US6686515B1
(en)
|
1999-11-23 |
2004-02-03 |
Maxygen, Inc. |
Homologous recombination in plants
|
|
IL150291A0
(en)
|
2000-01-11 |
2002-12-01 |
Maxygen Inc |
Integrated systems and methods for diversity generation and screening
|
|
EP1272967A2
(en)
|
2000-03-30 |
2003-01-08 |
Maxygen, Inc. |
In silico cross-over site selection
|
|
JP2004508011A
(ja)
|
2000-04-03 |
2004-03-18 |
マキシジェン， インコーポレイテッド |
スブチリシン変異体
|
|
EP1463807A4
(en)
|
2001-12-19 |
2006-04-12 |
Bristol Myers Squibb Co |
FORMATHYDROGENASE FROM PICHIA PASTORIS AND USES THEREOF
|
|
JP5319865B2
(ja)
|
2002-03-01 |
2013-10-16 |
コデクシス メイフラワー ホールディングス， エルエルシー |
機能的生体分子を同定する方法、システム、およびソフトウェア
|
|
US20050084907A1
(en)
|
2002-03-01 |
2005-04-21 |
Maxygen, Inc. |
Methods, systems, and software for identifying functional biomolecules
|
|
US7747391B2
(en)
|
2002-03-01 |
2010-06-29 |
Maxygen, Inc. |
Methods, systems, and software for identifying functional biomolecules
|
|
EP1488335A4
(en)
|
2002-03-09 |
2006-11-15 |
Maxygen Inc |
OPTIMIZING CROSSOVER POINTS FOR THE ADJUSTED EVOLUTION
|
|
ES2371913T3
(es)
|
2003-01-22 |
2012-01-11 |
Duke University |
Constructos mejorados para expresar polipéptidos lisosomales.
|
|
EP2287326A1
(en)
*
|
2003-08-08 |
2011-02-23 |
Arriva Pharmaceuticals, Inc. |
Methods of protein production in yeast
|
|
US20080014188A1
(en)
|
2004-02-06 |
2008-01-17 |
Zankel Todd C |
Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof
|
|
EP2886658A1
(en)
|
2005-03-10 |
2015-06-24 |
BASF Enzymes LLC |
Lyase enzymes, nucleic acids encoding them and methods for making and using them
|
|
EP3782655A1
(en)
|
2005-05-17 |
2021-02-24 |
Amicus Therapeutics, Inc. |
A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
|
|
US7531341B1
(en)
|
2006-06-12 |
2009-05-12 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
|
US7534595B2
(en)
|
2006-06-12 |
2009-05-19 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
|
US7560263B2
(en)
|
2007-08-17 |
2009-07-14 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
|
|
EP2250594B1
(en)
|
2008-02-12 |
2017-04-19 |
Codexis, Inc. |
Method of generating an optimized, diverse population of variants
|
|
US8504498B2
(en)
|
2008-02-12 |
2013-08-06 |
Codexis, Inc. |
Method of generating an optimized, diverse population of variants
|
|
US20090312196A1
(en)
|
2008-06-13 |
2009-12-17 |
Codexis, Inc. |
Method of synthesizing polynucleotide variants
|
|
DK3023494T3
(en)
|
2008-06-13 |
2019-02-25 |
Codexis Inc |
PROCEDURE FOR SYNTHESIS OF POLYNUCLEOTIDE VARIETIES
|
|
US8383346B2
(en)
|
2008-06-13 |
2013-02-26 |
Codexis, Inc. |
Combined automated parallel synthesis of polynucleotide variants
|
|
WO2010096369A1
(en)
|
2009-02-18 |
2010-08-26 |
Amicus Therapeutics, Inc. |
Mouse model for pompe disease and methods of use thereof
|
|
ES2690542T3
(es)
|
2010-02-04 |
2018-11-21 |
Biomarin Pharmaceutical Inc. |
Método para purificar variantes de fenilalanina amoníaco-liasa procariotas
|
|
DK2726651T3
(en)
|
2011-06-28 |
2019-01-28 |
Codexis Inc |
PROTEIN INVARIANT GENERATION BY REGION SHUFFLING
|
|
AR087433A1
(es)
*
|
2011-08-08 |
2014-03-26 |
Merck Sharp & Dohme |
Analogos de insulina n-glicosilados
|
|
EP2825647A4
(en)
|
2012-03-15 |
2015-10-14 |
Codexis Inc |
METHODS OF GENE REARRANGING
|
|
US9665694B2
(en)
|
2013-01-31 |
2017-05-30 |
Codexis, Inc. |
Methods, systems, and software for identifying bio-molecules with interacting components
|
|
BR112016006284B1
(pt)
|
2013-09-27 |
2022-07-26 |
Codexis, Inc |
Método implementado por computador, produto de programa de computador, e, sistema de computador
|
|
RU2016116253A
(ru)
|
2013-09-27 |
2017-11-01 |
Кодексис, Инк. |
Автоматизированный скрининг вариантов фермента
|
|
TW201618809A
(zh)
*
|
2014-06-13 |
2016-06-01 |
維理恩治療公司 |
用於治療肝醣儲積症及肝醣代謝病症之方法及組合物
|
|
MA41022A
(fr)
*
|
2014-11-24 |
2017-10-03 |
Shire Human Genetic Therapies |
Ciblage lysosomial et utilisations correspondantes
|
|
LT3237621T
(lt)
*
|
2014-12-22 |
2023-09-25 |
Codexis, Inc. |
Žmogaus alfa-galaktozidazės variantai
|
|
KR20250007693A
(ko)
|
2015-12-30 |
2025-01-14 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
폼페병 치료용의 강화된 산 알파-글루코시다제
|
|
EP3293203A1
(en)
*
|
2016-09-12 |
2018-03-14 |
Genethon |
Acid-alpha glucosidase variants and uses thereof
|
|
WO2019201855A1
(en)
*
|
2018-04-16 |
2019-10-24 |
Swedish Orphan Biovitrum Ab (Publ) |
Lysosomal fusion protein
|
|
MY207355A
(en)
|
2018-05-16 |
2025-02-21 |
Spark Therapeutics Inc |
Codon-optimized acid lpha-glucosidase expression cassettes and methods of using same
|
|
JP2023507575A
(ja)
|
2019-12-20 |
2023-02-24 |
コデクシス， インコーポレイテッド |
操作された酸性アルファ－グルコシダーゼバリアント
|
|
EP4735591A2
(en)
|
2023-06-30 |
2026-05-06 |
Crosswalk Therapeutics, Inc. |
Engineered acid alpha-glucosidase variants
|